Back to Search
Start Over
Rare-earth orthovanadate nanoparticles trigger Ca 2+ -dependent eryptosis.
- Source :
-
Nanotechnology [Nanotechnology] 2023 Mar 01; Vol. 34 (20). Date of Electronic Publication: 2023 Mar 01. - Publication Year :
- 2023
-
Abstract
- Introduction . Rare-earth orthovanadate nanoparticles (ReVO <subscript>4</subscript> :Eu <superscript>3+</superscript> , Re = Gd, Y or La) are promising agents for photodynamic therapy of cancer due to their modifiable redox properties. However, their toxicity limits their application. Objective . The aim of this research was to elucidate pro-eryptotic effects of GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> and LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles with identification of underlying mechanisms of eryptosis induction and to determine their pharmacological potential in eryptosis-related diseases. Methods . Blood samples ( n = 9) were incubated for 24 h with 0-10-20-40-80 mg l <superscript>-1</superscript> GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> or LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles, washed and used to prepare erythrocyte suspensions to analyze the cell membrane scrambling (annexin-V-FITC staining), cell shrinkage (forward scatter signaling), reactive oxygen species (ROS) generation through 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) staining and intracellular Ca <superscript>2+</superscript> levels via FLUO4 AM staining by flow cytometry. Internalization of europium-enabled luminescent GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> and LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles was assessed by confocal laser scanning microscopy. Results. Both nanoparticles triggered eryptosis at concentrations of 80 mg l <superscript>-1</superscript> . ROS-mediated mechanisms were not involved in rare-earth orthovanadate nanoparticles-induced eryptosis. Elevated cytosolic Ca <superscript>2+</superscript> concentrations were revealed even at subtoxic concentrations of nanoparticles. LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles increased intracellular calcium levels in a more pronounced way compared with GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles. Our data disclose that the small-sized (15 nm) GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles were internalized after a 24 h incubation, while the large-sized (∼30 nm) LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles were localized preferentially around erythrocytes. Conclusions. Both internalized GdVO <subscript>4</subscript> :Eu <superscript>3+</superscript> and non-internalized LaVO <subscript>4</subscript> :Eu <superscript>3+</superscript> nanoparticles (80 mg l <superscript>-1</superscript> ) promote eryptosis of erythrocytes after a 24 h exposure in vitro via Ca <superscript>2+</superscript> signaling without involvement of oxidative stress. Eryptosis is a promising model for assessing nanotoxicity.<br /> (© 2023 IOP Publishing Ltd.)
Details
- Language :
- English
- ISSN :
- 1361-6528
- Volume :
- 34
- Issue :
- 20
- Database :
- MEDLINE
- Journal :
- Nanotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 36780664
- Full Text :
- https://doi.org/10.1088/1361-6528/acbb7f